img

Response Dashboard

Partnering Opportunities

Tech Watch

If you are interested in partnering with the federal government on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners.

To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.

EZ BAA

Novel Coronavirus EZ-BAA

To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.

BAA

BARDA is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003).

Our COVID-19 Partnerships

BARDA'S Impact of Diagnostic Investments

Rapidly deploying test kits to Americans

14.5M+
Diagnostic Test Kits Shipped by Partners
*as of June 19, 2020